P03-596 - SWN (subjective well-being under neuroleptics) in clinical practice - 05/05/11
Résumé |
Objectives |
To assess the use of SWN in the acute phase of psychiatric disease as a predictor of clinical outcome.
Methods |
This study started in June 2009 and at the moment we have recruited 150 patients. The patients were divided into 4 groups according to their psychiatric diagnosis (schizophrenic psychosis, mood disorders, personality disorders, acute stress reaction) and each diagnostic group into three subgroups according to length of stay (T1< 7 days, T2=7–14 days, T3> 14 days). The subjective well-being indicators (subscales SWN: emotional regulation; self-control; mental functioning; social integration and physical functioning) and the severity of illness (CGI-S) were evaluated at admission and discharge.
Results |
At discharge there is a statistically significant difference in the SWN subgroups among the four diagnostic groups except for social integration and total score with equal CGI-S scores. Schizophrenic patients and personality disorders show a subjective improvement at T2; mood disorders at T3; acute stress reactions T1=T2. CGI shows a statistically improvement regardless of the length of stay.
Conclusions |
Preliminary data suggest that SWN represents a predictor of clinical outcome and remission and together with the clinical evaluation it can help clinician to settle therapeutic programs.
Le texte complet de cet article est disponible en PDF.
Vol 26 - N° S1
P. 1766 - 2011 Retour au numéro
Article précédent
- P03-595 - Crisis treatments: improvements in symptomatic, defense mechanisms, recovery style and social functioning
- A. Zanello, J.-P. Bacchetta, S. Quast, M. Merlo
- CS01-01 - Pathological gambling: impulse controle disorder or addiction?
- W. van den Brink
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?